BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6776566)

  • 1. Following several days of continuous administration d-amphetamine acquires hallucinogenlike properties.
    Nielsen EB; Lee TH; Ellison G
    Psychopharmacology (Berl); 1980; 68(2):197-200. PubMed ID: 6776566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral effects of LSD in the cat: proposal of an animal behavior model for studying the actions of hallucinogenic drugs.
    Jacobs BL; Trulson ME; Stern WC
    Brain Res; 1977 Aug; 132(2):301-14. PubMed ID: 19128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative alterations in rat behavior during continuous administration of LSD or mescaline: absence of tolerance?
    Ellison G; Ring M; Ross D; Axelrood B
    Biol Psychiatry; 1980 Feb; 15(1):95-102. PubMed ID: 7357060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural effects of some derivatives of amphetamine and LSD and their significance.
    Smythies JR; Beaton J; Benington F; Morin RD
    Nature; 1970 May; 226(5246):644-5. PubMed ID: 5444927
    [No Abstract]   [Full Text] [Related]  

  • 5. Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Feb; 184(2):376-84. PubMed ID: 4688175
    [No Abstract]   [Full Text] [Related]  

  • 6. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Heym J; Jacobs BL
    Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of some discriminative properties of d-amphetamine.
    Kuhn DM; Appel JB; Greenberg I
    Psychopharmacologia; 1974; 39(1):57-66. PubMed ID: 4138622
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of LSD, mescaline, and D-amphetamine on the evoked "secondary discharge".
    Roth WT
    Psychopharmacologia; 1966; 9(3):253-8. PubMed ID: 6010545
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists.
    Rasmussen K; Aghajanian GK
    Brain Res; 1986 Oct; 385(2):395-400. PubMed ID: 3096493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An animal behavior model for studying the actions of LSD and related hallucinogens.
    Jacobs BL; Trulson ME; Stern WC
    Science; 1976 Nov; 194(4266):741-3. PubMed ID: 982043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats.
    Cameron OG; Appel JB
    Psychopharmacologia; 1973; 33(2):117-34. PubMed ID: 4272898
    [No Abstract]   [Full Text] [Related]  

  • 12. The relative effectiveness of several hallucinogens in disrupting maze performance by rats.
    Uyeno ET; Mitoma C
    Psychopharmacologia; 1969; 16(1):73-80. PubMed ID: 5359329
    [No Abstract]   [Full Text] [Related]  

  • 13. The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism.
    Ellison G; Ratan R
    Life Sci; 1982 Aug; 31(8):771-7. PubMed ID: 7132578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent hallucinations in monkeys during around-the-clock amphetamine for seven to fourteen days. Possible relevance to amphetamine psychosis.
    Nielsen EB; Lyon M; Ellison G
    J Nerv Ment Dis; 1983 Apr; 171(4):222-33. PubMed ID: 6834023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI
    Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.
    Geyer MA; Petersen LR; Rose GJ; Horwitt DD; Light RK; Adams LM; Zook JA; Hawkins RL; Mandell AJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):837-47. PubMed ID: 731434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the pigment screening of the frog retina following administration of neuroactive drugs.
    Kemali M; Milici N; Kemali D
    Exp Eye Res; 1983 Nov; 37(5):493-8. PubMed ID: 6142827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross tolerance or tachyphylaxis among various psychotomimetic agents on cats.
    Wallach MB; Hine B; Gershon S
    Eur J Pharmacol; 1974 Nov; 29(1):89-92. PubMed ID: 4435048
    [No Abstract]   [Full Text] [Related]  

  • 19. The inhibition of food intake in the dog by LDS, mescaline, psilocin, d-amphetamine and phenylisopropylamine derivatives.
    Vaupel DB; Nozaki M; Martin WR; Bright LD; Morton EC
    Life Sci; 1979 Jun; 24(26):2427-31. PubMed ID: 481115
    [No Abstract]   [Full Text] [Related]  

  • 20. D-amphetamine as a discriminative cue: drugs with similar stimulus properties.
    Schechter MD; Rosecrans JA
    Eur J Pharmacol; 1973 Feb; 21(2):212-6. PubMed ID: 4696103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.